Actos Lawsuit Update - Click Here for More Information - Time is running out.
Please call Meyerkord & Kurth at 800-391-4318 in case you have some question regarding the Actos settlement amounts. A drug prescribed for the therapy of Type II diabetes, Actos, causes bladder cancer.
Immediate Call to Action- In recent Actos lawsuit news, Federal Court Judge Doherty has ruled that in order to be part of the $2.4 billion dollar Actos lawsuit settlement amount, you must sign a retainer arrangement with an attorney by Friday May 1st at mid-day. As stated by the New York Times the typical resolution may be $267,000 per victim.
As part of the Actos settlement Takeda has now consented to a $2.4 Billion Resolution fund to pay victims who used Actos before December 1, 2011 and developed bladder cancer.
In the event you used Actos and have been diagnosed with bladder cancer, call 800-391-4318 or complete the form to begin the process. This has to be done before Friday May 1 at noon Eastern.
Takeda Pharmaceutical Co, the manufacturer of Actos, profited $16 billion on its widely popular drug, Actos. While Takeda's internal Actos studies uncovered connections to bladder cancer as early as 2004, the firm did not alarm U.S. regulators until seven years after, according to Actos bladder cancer lawsuits filed by Actos attorneys.
When firms, like Takeda, place profits ahead of safety, their legal rights should be considered by personally injured victims.
There are almost 6,000 Actos Bladder Cancer Cases pending in courts. The lawyers at Meyerkord & Kurth proudly represent clients in the Actos Suit against Takeda Pharmaceutical.
In the event you or a loved one was diagnosed with bladder cancer and consider the analysis is the result of their use of Actos, our Actos Attorneys will probably be pleased to evaluate your claim with a fast, no charge assessment to see in the event you meet the requirements for the Actos Bladder Cancer Litigation.
Actos Lawsuit Settlement - Actos Bladder Cancer Injuries
With regards to a heightened bladder cancer risk linked to the employment of the diabetes drug Actos The FDA issued an Actos FDA Bladder Cancer Warning on June 15, 2011. This warning comes after an overview of information from a five-year interim evaluation of an on-going study of Actos by Takeda.
The results revealed that although there clearly was no increased risk of bladder cancer among Actos users general, there was an increased risk of bladder cancer amongst those who'd used the drug the longest. There was likewise a greater risk of bladder cancer among Actos users who'd been exposed to the maximum accumulative dose of the drug.
Actos, Takeda's Type2 Diabetes drug, grew in popularity after use of Avandia, GlaxoSmith Kline's controversial drug was seriously limited in the US because of concerns of a heightened risk of heart failure and heart attack last fall.
Meyerkord & Kurth, Actos Bladder Cancer Attorneys, consider that despite the Actos Bladder Cancer risk being known of by Takeda, Actos as safe and successful which resulted in lots of personally injured people were encouraged and advertised by Takeda.
Meyerkord & Kurth considers they should be held responsible for their actions when companies place profits ahead of safety.
Actos Bladder Cancer Litigation Settlement Verdict
You ought to consider inclusion in the Actos Litigation in the event you believe your bladder cancer analysis could have become the result of your Actos use. Contact an Actos Cancer Attorney like Meyerkord & Kurth to make sure your legal rights are considered. Meyerkord & Kurth will say honestly whether you should contemplate involvement in the Actos lawsuit. We're providing a no cost, no obligation overview of your medical history for possible inclusion in the Actos Bladder Cancer Litigation Settlement.